Price Target Analysis: Abeona Therapeutics Inc.(NASDAQ:ABEO) and Jacobs Engineering Group Inc.(NYSE:JEC)

0
4

Abeona Therapeutics Inc. (ABEO) will report its next earnings on Feb 08 AMC. The company reported the earnings of $-0.34/Share in the last quarter where the estimated EPS by analysts was $-0.26/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -30.8%.

Many analysts are providing their Estimated Earnings analysis for Abeona Therapeutics Inc. and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $-0.42/share. These analysts have also projected a Low Estimate of $-0.6/share and a High Estimate of $-0.31/share.

These analysts also forecasted Growth Estimates for the Current Quarter for ABEO to be -121.1%. They are projecting Next Quarter growth of -33.33%. For the next 5 years, Abeona Therapeutics Inc. is expecting Growth of -17.98% per annum, whereas in the past 5 years the growth was -72.73% per annum.

Some buy side analysts are also providing their Analysis on Abeona Therapeutics Inc., where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Abeona Therapeutics Inc. might touch $36 high while the Average Price Target and Low price Target is $26.38 and $17 respectively.

Abeona Therapeutics Inc. closed its last trading session at $7.31 with the loss of -1.09%. The Market Capitalization of the company stands at 347.11 Million. The Company has 52-week high of $22.00 and 52-week low of $6.26. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.56% where SMA50 and SMA200 are -8.44% and -45.68% respectively. The Company Touched its 52-Week High on 04/23/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.37 and Average Volume (3 months) is 719.3 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -26.4%. The Return on Equity (ROE) value stands at -27.7%. While it’s Return on Investment (ROI) value is -16.4%.

While looking at the Stock’s Performance, Abeona Therapeutics Inc. currently shows a Weekly Performance of 9.21%, where Monthly Performance is -19.76%, Quarterly performance is -32.87%, 6 Months performance is -51.96% and yearly performance percentage is -55.09%. Year to Date performance value (YTD perf) value is 1.26%. The Stock currently has a Weekly Volatility of 5.85% and Monthly Volatility of 7.34%.

Jacobs Engineering Group Inc. (JEC) will report its next earnings on Feb 19 BMO. The company reported the earnings of $1.31/Share in the last quarter where the estimated EPS by analysts was $1.24/share. The difference between the expected and actual EPS was $0.07/share, which represents an Earnings surprise of 5.6%.

Many analysts are providing their Estimated Earnings analysis for Jacobs Engineering Group Inc. and for the current quarter 11 analysts have projected that the stock could give an Average Earnings estimate of $1.07/share. These analysts have also projected a Low Estimate of $1/share and a High Estimate of $1.28/share.

In case of Revenue Estimates, 9 analysts have provided their consensus Average Revenue Estimates for Jacobs Engineering Group Inc. as 3.91 Billion. According to these analysts, the Low Revenue Estimate for Jacobs Engineering Group Inc. is 3.72 Billion and the High Revenue Estimate is 4.23 Billion. The company had Year Ago Sales of 2.75 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for JEC to be 36.4%. They are projecting Next Quarter growth of 27%. For the next 5 years, Jacobs Engineering Group Inc. is expecting Growth of 10.27% per annum, whereas in the past 5 years the growth was 16.55% per annum.

Some buy side analysts are also providing their Analysis on Jacobs Engineering Group Inc., where 6 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Jacobs Engineering Group Inc. might touch $94 high while the Average Price Target and Low price Target is $81.88 and $67 respectively.

Jacobs Engineering Group Inc. closed its last trading session at $60.15 with the gain of 1%. The Market Capitalization of the company stands at 8.64 Billion. The Company has 52-week high of $82.24 and 52-week low of $55.17. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 4.07% where SMA50 and SMA200 are -7.48% and -9.25% respectively. The Company Touched its 52-Week High on 11/08/18 and 52-Week Low on 12/26/18.

The Relative Volume of the company is 0.56 and Average Volume (3 months) is 1.5 million. The company’s P/E (price to earnings) ratio is 20.37 and Forward P/E ratio of 10.49.

The company shows its Return on Assets (ROA) value of 1.3%. The Return on Equity (ROE) value stands at 2.8%. While it’s Return on Investment (ROI) value is 6.3%.

While looking at the Stock’s Performance, Jacobs Engineering Group Inc. currently shows a Weekly Performance of 6.02%, where Monthly Performance is 3.21%, Quarterly performance is -20.75%, 6 Months performance is -7.11% and yearly performance percentage is -10.28%. Year to Date performance value (YTD perf) value is 3.92%. The Stock currently has a Weekly Volatility of 2.01% and Monthly Volatility of 2.80%.

SHARE